Suppr超能文献

无糖保护基条件下唾液酸-PAMAM 糖缀合物的合成评价及其抗 HIV-1 活性研究。

Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds.

机构信息

Department of Chemistry, California State University, Sacramento, California 95819-6057, United States.

出版信息

Bioconjug Chem. 2011 Oct 19;22(10):2186-97. doi: 10.1021/bc200331v. Epub 2011 Sep 6.

Abstract

A study was undertaken to evaluate the feasibility of synthesizing six sialic acid-PAMAM glycodendrimers using unprotected sialic acid in as few as 1-4 steps using two different reaction pathways, and to assess the sulfated derivatives for anti-HIV activity. The syntheses were accomplished through either the direct attachment of the sialic acid carboxyl group to amine-terminated PAMAM (a divergent-like approach) using BOP coupling, or by first reacting sialic acid with a polar bifunctional spacer molecule, attaching the sugar-linker to carboxy-terminated PAMAM (a convergent-like approach), and again using BOP-mediated coupling reactions. It was hypothesized that the latter approach would be the most successful method, as any steric congestion between the sialic acid and the PAMAM would be minimized using an intervening polar linker. However, the divergent-like synthesis proved to be the superior method, resulting in 11.4%, 14%, and 28% of the fully substituted generations 0, 1, and 2 sialic acid-PAMAM conjugates, respectively, as compared to 6.4% of only the generation -0.5 sialic acid-linker-PAMAM conjugate for the convergent-like method. Upon sulfation of the four glycodendrimers, binding capabilities to the recombinant HIV protein, gp120, were assessed using an ELISA assay. Compounds that showed promising binding characteristics were then further assessed for inhibition of HIV-1 infection using a well-characterized luciferase reporter gene neutralization assay. The generation 2 sulfated sialic acid-PAMAM glycodendrimer, sulfo-6, bearing 16 sialic acids with 11 sulfate groups incorporated at 4.03% sulfur content by weight, was found to inhibit all four HIV-1 strains tested in the low micromolar range.

摘要

一项研究旨在评估使用两种不同反应途径,通过非保护的唾液酸在 1-4 步内合成 6 种唾液酸-PAMAM 糖缀合物的可行性,同时评估硫酸化衍生物的抗 HIV 活性。这些合成是通过 BOP 偶联将唾液酸的羧基直接连接到伯胺末端的 PAMAM(发散样方法),或者首先将唾液酸与极性双功能间隔分子反应,将糖连接子连接到羧基末端的 PAMAM(收敛样方法),并再次使用 BOP 介导的偶联反应来完成。假设后一种方法将是最成功的方法,因为使用中间极性连接子可以最小化唾液酸和 PAMAM 之间的任何空间拥挤。然而,发散样合成被证明是优越的方法,分别得到完全取代的第 0、1 和 2 代唾液酸-PAMAM 缀合物的 11.4%、14%和 28%,而收敛样方法仅得到第-0.5 代唾液酸-连接子-PAMAM 缀合物的 6.4%。对四个糖缀合物进行硫酸化后,使用 ELISA 测定其与重组 HIV 蛋白 gp120 的结合能力。然后,对显示出有前途的结合特性的化合物进行进一步评估,以使用经过充分表征的荧光素酶报告基因中和测定法评估其抑制 HIV-1 感染的能力。带有 16 个唾液酸的第 2 代硫酸化唾液酸-PAMAM 糖缀合物 sulfo-6,其中 11 个硫酸根基团以 4.03%重量的硫含量掺入,被发现以低微摩尔范围抑制所有四种测试的 HIV-1 株。

相似文献

引用本文的文献

1
Sulfoglycodendron Antivirals with Scalable Architectures and Activities.具有可扩展结构和活性的硫酸化糖萜素抗病毒药物。
J Chem Inf Model. 2024 Sep 23;64(18):7141-7151. doi: 10.1021/acs.jcim.4c00541. Epub 2024 Sep 4.
7
Sulfoglycodendrimer Therapeutics for HIV-1 and SARS-CoV-2.用于治疗HIV-1和SARS-CoV-2的磺基糖树枝状大分子疗法
Adv Ther (Weinh). 2021 Apr;4(4):2000210. doi: 10.1002/adtp.202000210. Epub 2021 Feb 12.

本文引用的文献

5
Current status and challenges of antiretroviral research and therapy.抗逆转录病毒研究与治疗的现状与挑战。
Antiviral Res. 2010 Jan;85(1):25-33. doi: 10.1016/j.antiviral.2009.10.007. Epub 2009 Dec 16.
8
Non-polymeric nano-carriers in HIV/AIDS drug delivery and targeting.非聚合纳米载体在 HIV/AIDS 药物递送和靶向中的应用。
Adv Drug Deliv Rev. 2010 Mar 18;62(4-5):478-90. doi: 10.1016/j.addr.2009.11.018. Epub 2009 Nov 12.
10
Understanding and managing the adverse effects of antiretroviral therapy.了解和管理抗逆转录病毒疗法的不良反应。
Antiviral Res. 2010 Jan;85(1):201-9. doi: 10.1016/j.antiviral.2009.10.016. Epub 2009 Oct 24.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验